Arcturus Therapeutics Holdings Inc.
ARCT
$6.72
$0.172.60%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -116.23% | -46.49% | 34.78% | 53.09% | -334.67% |
| Total Depreciation and Amortization | -10.62% | -2.05% | -2.75% | -2.20% | -10.20% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 48.79% | -6.78% | -5.31% | -24.15% | -9.12% |
| Change in Net Operating Assets | 132.74% | -181.50% | 87.10% | -242.08% | 173.14% |
| Cash from Operations | 5.39% | -198.02% | 83.62% | -12,272.54% | 98.80% |
| Capital Expenditure | 148.62% | -- | 100.00% | -- | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 148.62% | -- | 100.00% | -- | 100.00% |
| Total Debt Issued | -- | -- | -100.00% | -- | -- |
| Total Debt Repaid | -- | 100.00% | -- | -- | -- |
| Issuance of Common Stock | 854.12% | 347.08% | 40.51% | 45.52% | -80.66% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 854.12% | 108.32% | -196.91% | 11,239.55% | -80.66% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 72.37% | 21.36% | -2.00% | -13,286.67% | 99.35% |